Efficacy of Butorphanol and Tramadol as an Adjuvant to Levobupivacaine for Postoperative Analgesia in Brachial Plexus Block – A Randomized Double-Blind Study
Vol 4 | Issue 1 | January-June 2023 | Page 07-12 | Jaya Lalwani, A. Sashank, Ravi Chaudhari
DOI: https://doi.org/10.13107/ijra.2023.v04i01.068
Authors: Jaya Lalwani [1], A. Sashank [1], Ravi Chaudhari [1]
[1] Department of Anaesthesia and Pain Management, Pt Jawaharlal Nehru Memorial Medical College, Raipur, Chhattisgarh, India.
Address of Correspondence
Dr. Ravi Chaudhari,
Department of Anaesthesia and Pain Management, Pt Jawaharlal Nehru Memorial Medical College, Raipur, Chhattisgarh, India.
E-mail: ravichaudharicc@gmail.com
Background: Supraclavicular brachial plexus block has evolved as a safe alternative to general anaesthesia with good postoperative analgesia. In an attempt to hasten the onset of block and increase the duration of postoperative analgesia, various adjuvant drugs are used along with local anesthetic agents.
Aim: The present study was undertaken to assess the analgesic efficacy of butorphanol (2mg) and tramadol (100 mg) as an adjuvant to levobupivacaine in supraclavicular brachial plexus block during perioperative period.
Study Design: This was a prospective, randomized, double blind study done on 100 adult patients of ASA I-III aged between 18-65 years and scheduled for various upper limb surgeries below the level of elbow.
Materials and Methodology: Patients were allocated by computer generated random draw into two groups of 50 each and were administered the study drugs under ultrasonographic guidance. Both groups received 22ml of the study drug (Group B 20 ml 0.5% levobupivacaine + Butorphanol 2mg and Group T 0.5% levobupivacaine + Tramadol 100 mg). Patients were assessed for duration of postoperative analgesia, onset & duration of sensory as well as motor blockade and occurrence of any side effects.
Results: Duration of postoperative analgesia was significantly elevated in group B (683±88.58 min), as compared to group T (483.2±45.24 min.) with p<0.001. Onset of sensory and motor blockade was comparable among both groups (p>0.05). Duration of sensory and motor block in group B was significantly longer compared to group T (p<0.001). Hemodynamics were stable and side effects were minimal in both the groups.
Conclusion: Butorphanol 2mg when added to 20ml 0.5% levobupivacaine in brachial plexus block, significantly prolongs the duration of postoperative analgesia, sensory and motor block as compared to addition of 100 mg tramadol, with minimal side effects and hemodynamic changes. However, these adjuvants shorten the onset times of sensory and motor block to a similar extent.
Keywords: Brachial plexus block, Levobupivacaine, Butorphanol, Tramadol, Analgesia.
References
[1] Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Prac. 2001;14: 211-18.
[2] El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth. 2018; 11:35-44
[3] Swain A, Nag DS, Sahu S, Samaddar DP. Adjuvants to local anesthetics: Current understanding and future trends. World J Clin Cases. 2017;5: 307-323.
[4] Bajwa SS, Kaur J. Clinical profile of levobupivacaine in regional anesthesia: A systematic review. J Anaesthesiology Clinical Pharmacology 2013;29: 530-39.
[5] Howard BG, Huda A. Opioid Analgesics. In:Goodman GA, Hardman G, Lee EL, editors. The pharmacological basis of therapeutics, Opioid analgesics. 10th ed. NewYork: McGraw Hill 2001.
[6] Vazzana M, et al. Tramadol hydrochloride: Pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother. 2015; 3586:1-5.
[7] Kumari A, Chhabra H, Gupta R, Kaur H. Comparative Study of Effectiveness of Tramadol and Butorphanol as Adjuvants to Levobupivacaine for Supraclavicular Brachial Plexus Block. Anesth Essays Res. 2019;13: 446-51.
[8] Foster RH, Markham A. Levobupivacaine: A review of its pharmacology and use as a local anaesthetic Drugs. 2000; 59:551–79.
[9] Edinoff A N et al. Adjuvant Drugs for Peripheral Nerve Blocks: The Role of Alpha-2 Agonists, Dexamethasone, Midazolam, and Non-steroidal Anti-inflammatory Drugs. Anesth Pain Med. 2021;11: 1-10.
[10] Desai N, Kirkham KR, Albrecht E. Local anaesthetic adjuncts for peripheral regional anaesthesia: A narrative review. Anaesthesia.2021;76: 100–09.
[11] Yilmaz E, Hough KA, Gebhart GF, Williams BA, Gold MS. Mechanisms underlying midazolam-induced peripheral nerve block and neurotoxicity. Reg Anesth Pain Med. 2014;39: 525–33.
[12] Krishna Prasad GV, Khanna S, Jaishree SV. Review of adjuvants to local anesthetics in peripheral nerve blocks: Current and future trends. Saudi J Anaesth 2020; 14:77‑84.
[13] Laudren PM. Axonal transport of opiate receptors in capsaicin-sensitive neurons. BrainResearch 1984; 68:413.
[14] Srikala V, Kumar MT. A Comparative Study of Buprenorphine Versus Butorphanol in Supraclavicular Brachial Plexus Block for Postoperative Analgesia. European Journal of Molecular & Clinical Medicine, 2022; 9: 2918-24.
[15] Bhavsar GM, Shah RB, Chavda HK, Shah VD, Bateriwala KM. Use of butorphanol as an adjuvant to local anaesthetics in brachial plexus block for upper limb surgery. PIJR. 2016;5: 169–72.
[16] Vinod CN, Talikoti DG. Comparison of Butorphanol and Buprenorphine as an Adjuvant to Local Anesthesia in Supraclavicular Brachial Plexus Block for Post-Operative Analgesia. Journal of Evolution of Medical and Dental Sciences 2014; 3: 4287-93
[17] Khosa A.H. & Asad, Naqibullah & Durrani, HAQ DAD. Does the addition of Tramadol to local anaesthetic mixture improve the quality of axillary brachial plexus block: A comparative study at the teaching hospital, Dera Ghazi Khan. Pakistan Journal of Medical and Health Sciences 2015;9: 1120-23.
[18] Bhatia U, Panjabi G, Patel A. Comparison of butorphanol and tramadol as an adjuvant to local anesthetic drug in axillary brachial plexus block. Ain-Shams J Anaesthesiology 2017;10: 242-46.
[19] Sharan R, Singh M, Attri J.P, Singh D. Additive effect of butorphanol in supraclavicular brachial plexus block. Int J Med Res Rev 2016;4: 910-17.
[20] Bharathi B, Praveena BL, Krishnaveni KN. Supraclavicular Brachial Plexus Block: Comparison of Varying Doses of Butorphanol Combined with Levobupivacaine – A Double-Blind Prospective Randomized Trial. Anesthesia Essays and Research. 2019;13: 174-78.
[21] Bommalingappa B, Channabasappa SM. Butorphanol as an adjuvant to levobupivacaine in supraclavicular brachial plexus block for upper limb orthopaedic surgeries: a randomized, double blind, placebo controlled study. J. Evolution Med. Dent. Sci. 2016;5: 4194-97.
| How to Cite this Article: Lalwani J, Sashank A, Chaudhari R | Efficacy of Butorphanol and Tramadol as an Adjuvant to Levobupivacaine for Postoperative Analgesia in Brachial Plexus Block – A Randomized Double-Blind Study | International Journal of Regional Anaesthesia | July-December 2023; 4(1): 07-12 | DOI: https://doi.org/10.13107/ijra.2023.v04i01.0068 |
